Intellectual Property

All of our intellectual property is developed in-house.

Breakthrough Technology

In 2015, the U.S. Patent Office granted OriginClear patent #9,085,745 for the first development of its two-stage electro-coagulation and -flotation process, Electro Water Separation™ (EWS),

“This patent defines a tubular electro-contact design and a flotation concept that we have scaled up to become our EWS technology platform,” said Nicholas Eckelberry, Chief Research Officer and co-founder. “This was a key beginning for us. We have since advanced our understanding of this process; our later patents build on this important first discovery.”

Early Development

In 2009, OriginClear invented its pioneering Single Step Extraction™ (SSE) process, and filed the first patent application on  April 17, 2009. The SSE application has been issued as a patent in Australia (image), Japan (image), China (link) and Mexico.  It has also been published by the European Patent Office (EPO) under the Patent Cooperation Treaty (PCT). SSE serves today as the first stage of Electro Water Separation™ (EWS).

Comprehensive Portfolio

Today, EWS is our common platform for an array of solutions in multiple industries. We are working to create a strong Intellectual Property portfolio around this suite of inventions, ensuring our domination of those fields of in which we operate.

We currently manage 43 applications worldwide, supporting the 11 key inventions in our portfolio.

Portfolio Listing:

Early Stage Inventions

During its first two years of operation, OriginClear innovated across the entire spectrum of algae production and processing. Early inventions of the period included:

The US Patent and Trademark Office has granted patents on two of these inventions, Quantum Fracturing (US#8,993,314) and Hydrogen Harvester (US#8,986,531).

OriginClear announced the transfer of Quantum Fracturing, the Helix Bioreactor and the Hydrogen Harvester to French joint venture, Ennesys, on October 22, 2013.

For licensing information, please contact us here.